Sakai Chemical Industry Co., Ltd. Provides Financial Guidance for the Six Months Ending September 30, 2022 and Full Year 2023
August 05, 2022 at 02:00 am EDT
Share
Sakai Chemical Industry Co., Ltd. provided financial guidance for the Six months ending September 30, 2022 and Full year 2023. For the Six months, the company expected net sales of JPY 42,500 million, operating income of JPY 3,700 million and Profit attributable to owners of parent of JPY 2,600 million and EPS of JPY 156.86.
For the Full year, the company expected net sales of JPY 85,000 million, operating income of JPY 7,000 million and Profit attributable to owners of parent of JPY 5,000 million and EPS of JPY 301.65.
SAKAI CHEMICAL INDUSTRY CO., LTD. is a Japan-based company principally manufactures and sells chemical industry products. The Company operates in two business segments. Chemical segment is involved in the manufacture and sale of chemical products. Main products include titanium products, resin additives, barium products, catalyst products, electronic materials, zinc products, functional materials, and other chemicals such as organophosphorus compounds, organic sulfur compounds, as well as water treatment agents, among others. Medical segment is involved in the manufacture and sale of pharmaceuticals and quasi drugs. Main products include barium X-ray contrast media, medical drugs for peptic ulcer & reflux esophagitis, general drugs such as cold and gastrointestinal drugs, functional foods, as well as other products such as medical devices, among others.
SAKAI CHEMICAL INDUSTRY CO., LTD. 
